Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
Kort samengevat
COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline. ...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij MarketScreener.
Lees het volledige bericht ↗